Grant: Project Grant
Sunnybrook Research Institute (Toronto, Ontario)
$392,256.00
A pilot pragmatic randomized controlled trial to evaluate the impact of improving access to drugs on type 2 diabetes care, outcomes and costs
EF 2017-18
Résumé
Canada is the only country with a universal health insurance system that does not provide coverage for prescription drugs to all residents. One-third of working-age Canadians have no insurance. Importantly, many of these uninsured patients already face other barriers to good health: low income, new immigrants, single mothers, etc. For these patients, taking prescription drugs - especially chronic disease treatments that may be required lifelong - can be difficult due to high costs. Patients skip doses, delay renewing prescriptions, or simply do not fill prescriptions recommended by their doctors, because they do not have insurance to cover the costs of prescriptions. The goal of our research is to understand whether providing free medications for these patients leads to better health care outcomes and is cost-effective.
Diabetes is a chronic disease common in working-age adults. People with diabetes are at risk for complications of the disease, but prescription drugs to treat blood sugar, blood pressure and cholesterol can reduce this risk. Previous research by our team has suggested that the lack of a universal drug insurance program for working-age Canadians affects the health and well-being of low-income people with diabetes. We will conduct a study to determine whether providing free prescription drugs for blood sugar, blood pressure and cholesterol for adults with diabetes under 65 reduces diabetes complications. This proposal is for a pilot study to make sure we can identify and recruit patients, implement the drug insurance intervention, and collect data on diabetes complications, mortality, risk factor control and healthcare system costs.
Programme
Project Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
370477
Name
Shah Baiju R
Region
Ontario
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Health Services and Policy Research
Theme2
Health systems / services
Prcname2
Health Services Evaluation & Interventions Research 2
Projecttitle
A pilot pragmatic randomized controlled trial to evaluate the impact of improving access to drugs on type 2 diabetes care, outcomes and costs
Programtype2
Operating Grants
Orgnameinp2
Sunnybrook Research Institute (Toronto, Ontario)
Cihramount2
$392,256
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Acces To Medications; Diabetes Mellitus; Health Equity; Pilot And Feasibility Study; Randomized Controlled Trial
Abstract
Canada is the only country with a universal health insurance system that does not provide coverage for prescription drugs to all residents. One-third of working-age Canadians have no insurance. Importantly, many of these uninsured patients already face other barriers to good health: low income, new immigrants, single mothers, etc. For these patients, taking prescription drugs - especially chronic disease treatments that may be required lifelong - can be difficult due to high costs. Patients skip doses, delay renewing prescriptions, or simply do not fill prescriptions recommended by their doctors, because they do not have insurance to cover the costs of prescriptions. The goal of our research is to understand whether providing free medications for these patients leads to better health care outcomes and is cost-effective.
Diabetes is a chronic disease common in working-age adults. People with diabetes are at risk for complications of the disease, but prescription drugs to treat blood sugar, blood pressure and cholesterol can reduce this risk. Previous research by our team has suggested that the lack of a universal drug insurance program for working-age Canadians affects the health and well-being of low-income people with diabetes. We will conduct a study to determine whether providing free prescription drugs for blood sugar, blood pressure and cholesterol for adults with diabetes under 65 reduces diabetes complications. This proposal is for a pilot study to make sure we can identify and recruit patients, implement the drug insurance intervention, and collect data on diabetes complications, mortality, risk factor control and healthcare system costs.
Competitiondate
201709
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Shah, Baiju R; Tu, Karen
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $392,256~ $0~